Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

Inconsistent platelet counts in PRP are due to varying blood volumes, preparation methods, and analyzer types.

Pregnancy and parenthood may help regulate PCOS symptoms.

Iron levels are linked to sleep apnea severity, especially in women with hair loss.

The combined therapy improved fertility in women with PCOS, especially in certain types.

Oral minoxidil users, especially for hypertension, may risk heart issues, and better monitoring guidelines are needed for alopecia patients.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

Finasteride use may increase suicidality risk, especially in young men.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

Dutasteride and finasteride do not increase mood disorder risk in men with hair loss.

Oral minoxidil rarely causes pericardial effusion, especially at low doses.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

Dutasteride 0.5 mg is safe and effective for long-term use in Korean men with hair loss.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Dutasteride is safe and effective long-term for male hair loss.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Pregnancy and parenthood do not significantly change PCOS symptoms, but childless women have less hirsutism and weight gain.

The new X-ray technique allows for precise and non-destructive measurement of elements in hair, creating the first database of its kind for a specific ethnic group.

Rare genetic variants in 125 genes are linked to male-pattern hair loss.

Finasteride users have higher odds of certain health issues and lower odds of specific lifestyle factors compared to nonusers.